Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT).
Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Hozawa H, Kawai K, Awata M, Mukawa H, Fujita H, Shiode N, Asano R, Tsukamoto Y, Yamada T, Yasumura Y, Ohira H, Miyamoto A, Takashima H, Ogawa T, Matsuyama Y, Nanto S; J-DESsERT investigators. Nakamura M, et al. Among authors: matsuyama y. Cardiovasc Interv Ther. 2015 Apr;30(2):103-14. doi: 10.1007/s12928-014-0279-z. Epub 2014 Jun 27. Cardiovasc Interv Ther. 2015. PMID: 24969222 Clinical Trial.
Comparison of sirolimus- and paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trial.
Otsuka M, Yokoi H, Matsuyama Y, Hayashi Y, Shiode N, Masaoka Y, Okimoto T, Tamekiyo H, Kawase T, Yamane K, Kagawa Y, Nakamura M, Muramatsu T, Nanto S; J-DESsERT investigators. Otsuka M, et al. Among authors: matsuyama y. Cardiovasc Revasc Med. 2014 Sep-Oct;15(6-7):323-8. doi: 10.1016/j.carrev.2014.09.003. Epub 2014 Sep 16. Cardiovasc Revasc Med. 2014. PMID: 25284808 Clinical Trial.
Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trial.
Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Hozawa H, Kawai K, Awata M, Mukawa H, Fujita H, Shiode N, Asano R, Tsukamoto Y, Yamada T, Yasumura Y, Ohira H, Miyamoto A, Takashima H, Ogawa T, Ito S, Matsuyama Y, Nanto S; J-DESsERT Investigators. Nakamura M, et al. Among authors: matsuyama y. Int J Cardiol. 2016 Apr 1;208:4-12. doi: 10.1016/j.ijcard.2016.01.023. Epub 2016 Jan 11. Int J Cardiol. 2016. PMID: 26826622 Clinical Trial.
Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
Kitahara H, Waseda K, Sakamoto K, Yamada R, Huang CC, Nakatani D, Sakata K, Kawarada O, Yock PG, Matsuyama Y, Yokoi H, Nakamura M, Muramatsu T, Nanto S, Fitzgerald PJ, Honda Y. Kitahara H, et al. Among authors: matsuyama y. Atherosclerosis. 2017 Apr;259:68-74. doi: 10.1016/j.atherosclerosis.2017.02.009. Epub 2017 Feb 20. Atherosclerosis. 2017. PMID: 28327450 Clinical Trial.
Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation: development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Japan.
Kozuma K, Kozuma K, Shinozaki T, Kashiwabara K, Oba K; Xience P. M. S. Group; PROMUS Element/Element Plus P. M. S. Group; Matsuyama Y. Kozuma K, et al. Among authors: matsuyama y. Cardiovasc Interv Ther. 2021 Apr;36(2):190-197. doi: 10.1007/s12928-020-00666-2. Epub 2020 Apr 18. Cardiovasc Interv Ther. 2021. PMID: 32306206
1,054 results